Similar articles

• A review of immunotherapy.

  Norman PS. Norman PS. Allergy. 1978 Apr;33(2):62-70. doi: 10.1111/j.1398-9995.1978.tb01510.x. Allergy. 1978. PMID: 80138 Review. No abstract available.
• Immunotherapy.

  Norman PS. Norman PS. Prog Allergy. 1982;32:318-46. doi: 10.1159/000318291. Prog Allergy. 1982. PMID: 6750621 Review. No abstract available.
• Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.

  Rossi RE, Monasterolo G. Rossi RE, et al. Int Arch Allergy Immunol. 2004 Sep;135(1):44-53. doi: 10.1159/000080042. Epub 2004 Jul 30. Int Arch Allergy Immunol. 2004. PMID: 15286445
• A short assessment of sublingual immunotherapy.

  Rakoski J, Wessner D. Rakoski J, et al. Int Arch Allergy Immunol. 2001 Nov;126(3):185-7. doi: 10.1159/000049512. Int Arch Allergy Immunol. 2001. PMID: 11752874 Review. No abstract available.
• Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children.

  Niggemann B, Jacobsen L, Dreborg S, Ferdousi HA, Halken S, Høst A, Koivikko A, Koller D, Norberg LA, Urbanek R, Valovirta E, Wahn U, Möller C; PAT Investigator Group. Niggemann B, et al. Allergy. 2006 Jul;61(7):855-9. doi: 10.1111/j.1398-9995.2006.01068.x. Allergy. 2006. PMID: 16792584 Clinical Trial.